Tirzepatide, a innovative medication, is sparking considerable excitement within the scientific community. It operates differently from traditional diabetes treatments , targeting two receptors involved in glucose regulation and satiety. Initial research have demonstrated remarkable efficacy in reducing blood glucose in individuals with adult-onset